After a Series of Acquisitions, Fisher Expects 2006 Sales to Grow Around 10 Percent | GenomeWeb

Fisher Scientific officials said this week that they expect their recent string of acquisitions, among other initiatives, to help 2006 sales grow by between 9 percent and 11 percent.

Fisher has been aggressive in the M&A market so far this year, acquiring four firms for more than $400 million. Following a year in which the firm purchased a total of four companies, Paul Meister, vice chairman of Fisher, said during the firm's first-quarter conference call this week, "The pace [of acquisitions] has obviously picked up."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.